Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
35.8M
-
Shares change
-
+9.79M
-
Total reported value, excl. options
-
$1.12B
-
Value change
-
+$319M
-
Put/Call ratio
-
0.03
-
Number of buys
-
60
-
Number of sells
-
-31
-
Price
-
$31.16
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q2 2015
106 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q2 2015.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.8M shares
of 183M outstanding shares and own 19.56% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (6.36M shares), TANG CAPITAL MANAGEMENT LLC (5.19M shares), BAKER BROS. ADVISORS LP (2.81M shares), Broadfin Capital, LLC (2.4M shares), Partner Fund Management, L.P. (1.81M shares), FMR LLC (1.77M shares), Cormorant Asset Management, LLC (1.44M shares), JANUS CAPITAL MANAGEMENT LLC (1.36M shares), STATE STREET CORP (1.2M shares), and VHCP Management, LLC (1.1M shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.